WATERTOWN, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc., a second generation RNA interference (RNAi) company developing novel therapeutics utilizing its proprietary Dicer Substrate Technology™ and dicer substrate RNAi molecules, today announced that Sujit K. Basu, Ph.D., senior director, formulation, will be presenting at Biologics Drug Delivery & Beyond, being held September 23-25, 2009 at the Sheraton Hotel in Boston.
